Chemical Structure : Efipladib
货号: PC-61845Not For Human Use, Lab Use Only.
Efipladib (PLA 902) is a potent, selective and orally active inhibitor of cPLA2α with IC50 of 20 nM for LTB4 inhibition.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Efipladib (PLA 902) is a potent, selective and orally active inhibitor of cPLA2α with IC50 of 20 nM for LTB4 inhibition.
Efipladib (PLA 902) shows efficacy in multiple acute and chronic prostaglandin and leukotriene dependent in vivo models.
Efipladib (PLA 902) also decreases basal and EGF-stimulated AKT phosphorylation and proliferation in HT-29 cancer cells, reduces xenograft growth by >90% with a concomitant decrease in AKT phosphorylation in mice (10 mg/kg, i.p. daily, >14 days).
分子量 | 746.14 | |
分子式 | C40H35Cl3N2O4S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. McKew JC, et al. J Med Chem. 2008 Jun 26;51(12):3388-413.
2. Nickerson-Nutter CL, et al. Neuropharmacology. 2011 Mar;60(4):633-41.
3. Zheng Z, et al. Oncotarget. 2014 Dec 15;5(23):12304-16.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright